2025-04-012026-03-312026-03-31false08534546RHINOPED MEDICAL LIMITED2026-09-14falseiso4217:GBPxbrli:pure085345462025-03-31085345462026-03-31085345462025-04-012026-03-31085345462024-03-31085345462025-03-31085345462024-04-012025-03-3108534546bus:SmallEntities2025-04-012026-03-3108534546bus:AuditExempt-NoAccountantsReport2025-04-012026-03-3108534546bus:FullAccounts2025-04-012026-03-3108534546bus:PrivateLimitedCompanyLtd2025-04-012026-03-3108534546core:WithinOneYear2026-03-3108534546core:AfterOneYear2026-03-3108534546core:WithinOneYear2025-03-3108534546core:AfterOneYear2025-03-3108534546core:ShareCapital2026-03-3108534546core:SharePremium2026-03-3108534546core:RevaluationReserve2026-03-3108534546core:OtherReservesSubtotal2026-03-3108534546core:RetainedEarningsAccumulatedLosses2026-03-3108534546core:ShareCapital2025-03-3108534546core:SharePremium2025-03-3108534546core:RevaluationReserve2025-03-3108534546core:OtherReservesSubtotal2025-03-3108534546core:RetainedEarningsAccumulatedLosses2025-03-3108534546core:LandBuildings2026-03-3108534546core:PlantMachinery2026-03-3108534546core:Vehicles2026-03-3108534546core:FurnitureFittings2026-03-3108534546core:OfficeEquipment2026-03-3108534546core:NetGoodwill2026-03-3108534546core:IntangibleAssetsOtherThanGoodwill2026-03-3108534546core:ListedExchangeTraded2026-03-3108534546core:UnlistedNon-exchangeTraded2026-03-3108534546core:LandBuildings2025-03-3108534546core:PlantMachinery2025-03-3108534546core:Vehicles2025-03-3108534546core:FurnitureFittings2025-03-3108534546core:OfficeEquipment2025-03-3108534546core:NetGoodwill2025-03-3108534546core:IntangibleAssetsOtherThanGoodwill2025-03-3108534546core:ListedExchangeTraded2025-03-3108534546core:UnlistedNon-exchangeTraded2025-03-3108534546core:LandBuildings2025-04-012026-03-3108534546core:PlantMachinery2025-04-012026-03-3108534546core:Vehicles2025-04-012026-03-3108534546core:FurnitureFittings2025-04-012026-03-3108534546core:OfficeEquipment2025-04-012026-03-3108534546core:NetGoodwill2025-04-012026-03-3108534546core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3108534546core:ListedExchangeTraded2025-04-012026-03-3108534546core:UnlistedNon-exchangeTraded2025-04-012026-03-3108534546core:MoreThanFiveYears2025-04-012026-03-3108534546core:Non-currentFinancialInstruments2026-03-3108534546core:Non-currentFinancialInstruments2025-03-3108534546dpl:CostSales2025-04-012026-03-3108534546dpl:DistributionCosts2025-04-012026-03-3108534546core:LandBuildings2025-04-012026-03-3108534546core:PlantMachinery2025-04-012026-03-3108534546core:Vehicles2025-04-012026-03-3108534546core:FurnitureFittings2025-04-012026-03-3108534546core:OfficeEquipment2025-04-012026-03-3108534546dpl:AdministrativeExpenses2025-04-012026-03-3108534546core:NetGoodwill2025-04-012026-03-3108534546core:IntangibleAssetsOtherThanGoodwill2025-04-012026-03-3108534546dpl:GroupUndertakings2025-04-012026-03-3108534546dpl:ParticipatingInterests2025-04-012026-03-3108534546dpl:GroupUndertakingscore:ListedExchangeTraded2025-04-012026-03-3108534546core:ListedExchangeTraded2025-04-012026-03-3108534546dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-04-012026-03-3108534546core:UnlistedNon-exchangeTraded2025-04-012026-03-3108534546dpl:CostSales2024-04-012025-03-3108534546dpl:DistributionCosts2024-04-012025-03-3108534546core:LandBuildings2024-04-012025-03-3108534546core:PlantMachinery2024-04-012025-03-3108534546core:Vehicles2024-04-012025-03-3108534546core:FurnitureFittings2024-04-012025-03-3108534546core:OfficeEquipment2024-04-012025-03-3108534546dpl:AdministrativeExpenses2024-04-012025-03-3108534546core:NetGoodwill2024-04-012025-03-3108534546core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108534546dpl:GroupUndertakings2024-04-012025-03-3108534546dpl:ParticipatingInterests2024-04-012025-03-3108534546dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3108534546core:ListedExchangeTraded2024-04-012025-03-3108534546dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3108534546core:UnlistedNon-exchangeTraded2024-04-012025-03-3108534546core:NetGoodwill2026-03-3108534546core:IntangibleAssetsOtherThanGoodwill2026-03-3108534546core:LandBuildings2026-03-3108534546core:PlantMachinery2026-03-3108534546core:Vehicles2026-03-3108534546core:FurnitureFittings2026-03-3108534546core:OfficeEquipment2026-03-3108534546core:AfterOneYear2026-03-3108534546core:WithinOneYear2026-03-3108534546core:ListedExchangeTraded2026-03-3108534546core:UnlistedNon-exchangeTraded2026-03-3108534546core:ShareCapital2026-03-3108534546core:SharePremium2026-03-3108534546core:RevaluationReserve2026-03-3108534546core:OtherReservesSubtotal2026-03-3108534546core:RetainedEarningsAccumulatedLosses2026-03-3108534546core:NetGoodwill2025-03-3108534546core:IntangibleAssetsOtherThanGoodwill2025-03-3108534546core:LandBuildings2025-03-3108534546core:PlantMachinery2025-03-3108534546core:Vehicles2025-03-3108534546core:FurnitureFittings2025-03-3108534546core:OfficeEquipment2025-03-3108534546core:AfterOneYear2025-03-3108534546core:WithinOneYear2025-03-3108534546core:ListedExchangeTraded2025-03-3108534546core:UnlistedNon-exchangeTraded2025-03-3108534546core:ShareCapital2025-03-3108534546core:SharePremium2025-03-3108534546core:RevaluationReserve2025-03-3108534546core:OtherReservesSubtotal2025-03-3108534546core:RetainedEarningsAccumulatedLosses2025-03-3108534546core:NetGoodwill2024-03-3108534546core:IntangibleAssetsOtherThanGoodwill2024-03-3108534546core:LandBuildings2024-03-3108534546core:PlantMachinery2024-03-3108534546core:Vehicles2024-03-3108534546core:FurnitureFittings2024-03-3108534546core:OfficeEquipment2024-03-3108534546core:AfterOneYear2024-03-3108534546core:WithinOneYear2024-03-3108534546core:ListedExchangeTraded2024-03-3108534546core:UnlistedNon-exchangeTraded2024-03-3108534546core:ShareCapital2024-03-3108534546core:SharePremium2024-03-3108534546core:RevaluationReserve2024-03-3108534546core:OtherReservesSubtotal2024-03-3108534546core:RetainedEarningsAccumulatedLosses2024-03-3108534546core:AfterOneYear2025-04-012026-03-3108534546core:WithinOneYear2025-04-012026-03-3108534546core:Non-currentFinancialInstrumentscore:CostValuation2025-04-012026-03-3108534546core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-012026-03-3108534546core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-012026-03-3108534546core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-012026-03-3108534546core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-012026-03-3108534546core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-012026-03-3108534546core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3108534546core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3108534546core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-012026-03-3108534546core:Non-currentFinancialInstrumentscore:CostValuation2026-03-3108534546core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-03-3108534546core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-03-3108534546core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-03-3108534546core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-03-3108534546core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-03-3108534546core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2026-03-3108534546core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-03-3108534546core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-03-3108534546core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3108534546core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3108534546core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3108534546core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3108534546core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3108534546core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3108534546core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3108534546core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3108534546core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3108534546bus:Director12025-04-012026-03-3108534546bus:Director22025-04-012026-03-3108534546core:FurnitureFittingsToolsEquipment2025-03-3108534546core:FurnitureFittingsToolsEquipment2026-03-3108534546core:FurnitureFittingsToolsEquipment2025-04-012026-03-31

RHINOPED MEDICAL LIMITED

Registered Number
08534546
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2026

RHINOPED MEDICAL LIMITED
Company Information
for the year from 1 April 2025 to 31 March 2026

Directors

BRACEWELL, Melissa Anne, Dr
HARRIES, Philip Gerald

Registered Address

1st Floor, Buckley House 31a The Hundred
Romsey
SO51 8GD

Registered Number

08534546 (England and Wales)
RHINOPED MEDICAL LIMITED
Balance Sheet as at
31 March 2026

Notes

2026

2025

£

£

£

£

Fixed assets
Tangible assets344,20659,735
44,20659,735
Current assets
Debtors425,48124,811
Cash at bank and on hand237,507218,035
262,988242,846
Creditors amounts falling due within one year5(82,633)(60,900)
Net current assets (liabilities)180,355181,946
Total assets less current liabilities224,561241,681
Creditors amounts falling due after one year6(43,567)(50,565)
Net assets180,994191,116
Capital and reserves
Called up share capital150150
Profit and loss account180,844190,966
Shareholders' funds180,994191,116
The financial statements were approved and authorised for issue by the Board of Directors on 14 September 2026, and are signed on its behalf by:
HARRIES, Philip Gerald
Director
Registered Company No. 08534546
RHINOPED MEDICAL LIMITED
Notes to the Financial Statements
for the year ended 31 March 2026

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis of accounting in preparing its financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Reducing balance (%)
Plant and machinery50
Fixtures and fittings25
Vehicles25
Office Equipment25
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
2.Average number of employees

20262025
Average number of employees during the year22
3.Tangible fixed assets

Plant & machinery

Vehicles

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 April 2516,32162,7752,5342,68284,312
At 31 March 2616,32162,7752,5342,68284,312
Depreciation and impairment
At 01 April 2513,9386,4921,4652,68224,577
Charge for year1,19114,071267-15,529
At 31 March 2615,12920,5631,7322,68240,106
Net book value
At 31 March 261,19242,212802-44,206
At 31 March 252,38356,2831,069-59,735
4.Debtors: amounts due within one year

2026

2025

££
Trade debtors / trade receivables25,48124,811
Total25,48124,811
5.Creditors: amounts due within one year

2026

2025

££
Trade creditors / trade payables6,5076,703
Taxation and social security62,41842,046
Finance lease and HP contracts7,5897,109
Other creditors3,4781,862
Accrued liabilities and deferred income2,6413,180
Total82,63360,900
6.Creditors: amounts due after one year

2026

2025

££
Other creditors43,56750,565
Total43,56750,565
7.Obligations under finance leases

2026

2025

££
Finance lease and HP contracts51,15657,674